Reduced food intake and body weight in mice deficient for the G protein-coupled receptor GPR82

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Engel, Kathrin M Y ^a   Schröck, Kristin ^a   Teupser, Daniel ^a   Holdt, Lesca Miriam ^a   Tönjes, Anke ^a   Kern, Matthias ^a   Dietrich, Kerstin ^b   Kovacs, Peter ^b   Krügel, Ute ^a   Scheidt, Holger A ^a   Schiller, Jürgen ^a   Huster, Daniel ^a   Brockmann, Gudrun A ^c   Augustin, Martin ^d   Thiery, Joachim ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Schöneberg, Torsten ^a,e   Schulz, Angela ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Ingenium Pharmaceuticals AG   (Germany)

^e MILLIPORE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GPR82 PROTIEN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY WEIGHT; BREATHING RATE; CALCIUM CALMODULIN DEPENDENT SERINE PROTEIN KINASE LOCUS; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FOOD INTAKE; GENE; GENE LOCUS; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE TOLERANCE; GPR82 GENE; HUMAN; INSULIN SENSITIVITY; KNOCKOUT MOUSE; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE; X CHROMOSOME; ANIMAL; BLOOD; DIET; FEEDING BEHAVIOR; GENETICS; GENOTYPE; GLUCOSE TOLERANCE TEST; MOUSE MUTANT; PHENOTYPE; PHYSIOLOGY;

MUS;

ANIMALS; BODY WEIGHT; DIET; FEEDING BEHAVIOR; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; MICE; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, G-PROTEIN-COUPLED; TRIGLYCERIDES; X CHROMOSOME;

EID: 84555218971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029400     Document Type: Article

References (44)

1. Akey JM, Eberle MA, Rieder MJ, Carlson CS, Shriver MD, et al. (2004) Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol 2: e286.
2. Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Hubisz MT, et al. (2005) Natural selection on protein-coding genes in the human genome. Nature 437: 1153-1157.
3. Nielsen R, Bustamante C, Clark AG, Glanowski S, Sackton TB, et al. (2005) A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol 3: e170.
4. Nielsen R, Williamson S, Kim Y, Hubisz MJ, Clark AG, et al. (2005) Genomic scans for selective sweeps using SNP data. Genome Res 15: 1566-1575.
5. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, et al. (2006) Positive natural selection in the human lineage. Science 312: 1614-1620.
6. Voight BF, Kudaravalli S, Wen X, Pritchard JK, (2006) A map of recent positive selection in the human genome. PLoS Biol 4: e72.
7. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, et al. (2007) Genome-wide detection and characterization of positive selection in human populations. Nature 449: 913-918.
8. Gloriam DE, Fredriksson R, Schioth HB, (2007) The G protein-coupled receptor subset of the rat genome. BMC Genomics 8: 338.
9. Strotmann R, Schrock K, Boselt I, Staubert C, Russ A, et al. (2011) Evolution of GPCR: Change and continuity. Mol Cell Endocrinol 331: 170-178.
10. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409: 202-207.
11. Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107: 1591-1598.
12. Schoneberg T, Hermsdorf T, Engemaier E, Engel K, Liebscher I, et al. (2007) Structural and functional evolution of the P2Y(12)-like receptor group. Purinergic Signal 3: 255-268.
13. Tabata K, Baba K, Shiraishi A, Ito M, Fujita N, (2007) The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 363: 861-866.
14. Nonaka Y, Hiramoto T, Fujita N, (2005) Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun 337: 281-288.
15. Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, et al. (2006) Identification of a lysophosphatidylserine receptor on mast cells. Biochemical and Biophysical Research Communications 341: 1078-1087.
16. Yin H, Chu A, Li W, Wang B, Shelton F, et al. (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328-12338.
17. Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, et al. (2001) Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275: 83-91.
18. Atasoy D, Schoch S, Ho A, Nadasy KA, Liu X, et al. (2007) Deletion of CASK in mice is lethal and impairs synaptic function. Proc Natl Acad Sci U S A 104: 2525-2530.
19. Liebscher I, Muller U, Teupser D, Engemaier E, Engel KM, et al. (2011) Altered immune response in mice deficient for the G protein-coupled receptor GPR34. J Biol Chem 286: 2101-2110.
20. Tonjes A, Koriath M, Schleinitz D, Dietrich K, Bottcher Y, et al. (2009) Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet 18: 4662-4668.
21. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25-38.
22. Bjorbaek C, Kahn BB, (2004) Leptin Signaling in the Central Nervous System and the Periphery. Recent Prog Horm Res 59: 305-331.
23. Schiller J, Süß R, Petković M, Arnold K, (2002) Triacylglycerol analysis of vegetable oils by matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry and 31P NMR spectroscopy. J Food Lipids 9: 185-200.
24. Bottcher Y, Unbehauen H, Kloting N, Ruschke K, Korner A, et al. (2009) Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes 58: 2119-2128.
25. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, et al. (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30: 620-627.
26. Mukherjee K, Sharma M, Urlaub H, Bourenkov GP, Jahn R, et al. (2008) CASK Functions as a Mg2+-independent neurexin kinase. Cell 133: 328-339.
27. Engemaier E, Rompler H, Schoneberg T, Schulz A, (2006) Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34. Genomics 87: 254-264.
28. Schoneberg T, Schulz A, Grosse R, Schade R, Henklein P, et al. (1999) A novel subgroup of class I G-protein-coupled receptors. Biochim Biophys Acta 1446: 57-70.
29. Schulz A, Schoneberg T, (2003) The structural evolution of a P2Y-like G-protein-coupled receptor. J Biol Chem 278: 35531-35541.
30. Despres JP, (1998) The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res 6 (Suppl 1): 8S-17S.
31. Moller DE, (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827.
32. Salto C, Kindblom JM, Johansson C, Wang Z, Gullberg H, et al. (2001) Ablation of TRalpha2 and a concomitant overexpression of alpha1 yields a mixed hypo- and hyperthyroid phenotype in mice. Mol Endocrinol 15: 2115-2128.
33. Kim-Saijo M, Akamizu T, Ikuta K, Iida Y, Ohmori K, et al. (2003) Generation of a transgenic animal model of hyperthyroid Graves' disease. Eur J Immunol 33: 2531-2538.
34. Decherf S, Seugnet I, Kouidhi S, Lopez-Juarez A, Clerget-Froidevaux MS, et al. (2010) Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proc Natl Acad Sci U S A 107: 4471-4476.
35. (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
36. Tajima F, (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
37. Fu YX, Li WH, (1993) Statistical tests of neutrality of mutations. Genetics 133: 693-709.
38. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
39. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
40. Masuya H, Inoue M, Wada Y, Shimizu A, Nagano J, et al. (2005) Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program. Mammalian Genome 16: 829-837.
41. Rogers DC, Fisher EMC, Brown SDM, Peters J, Hunter AJ, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mammalian Genome 8: 711-713.
42. Huster D, Arnold K, Gawrisch K, (1998) Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 37: 17299-17308.
43. Fuchs B, Suss R, Schiller J, (2010) An update of MALDI-TOF mass spectrometry in lipid research. Prog Lipid Res 49: 450-475.
44. Teuber K, Schiller J, Fuchs B, Karas M, Jaskolla TW, (2010) Significant sensitivity improvements by matrix optimization: a MALDI-TOF mass spectrometric study of lipids from hen egg yolk. Chem Phys Lipids 163: 552-560.